MARKET WIRE NEWS

Exagen Inc. (XGN) Q2 2025 Earnings Call Transcript

Source: SeekingAlpha

2025-07-29 15:09:37 ET

Exagen Inc. (XGN)

Q2 2025 Earnings Conference Call

July 29, 2025, 08:30 AM ET

Company Participants

Jeffrey G. Black - CFO & Corporate Secretary

John Aballi - CEO, President & Director

Ryan Douglas - Investors Relations Officer

Conference Call Participants

Kyle Alexander Mikson - Canaccord Genuity Corp., Research Division

Margarate Elizabeth Boeye - William Blair & Company L.L.C., Research Division

Ross Everett Osborn - Cantor Fitzgerald & Co., Research Division

William Ruby - TD Cowen, Research Division

Presentation

Operator

Greetings, and welcome to the Exagen Inc. Q2 2025 Earnings Call. [Operator Instructions]. As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Ryan Douglas, Investor Relations. Thank you. You may begin....

Read the full article on Seeking Alpha

For further details see:

Exagen Inc. (XGN) Q2 2025 Earnings Call Transcript
Exagen Inc.

NASDAQ: XGN

XGN Trading

-9.09% G/L:

$3 Last:

86,226 Volume:

$3.40 Open:

mwn-link-x Ad 300

XGN Latest News

XGN Stock Data

$80,000,739
13,869,817
3.15%
15
N/A
Medical Diagnostics & Screening
Healthcare
US
Vista

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App